Literature DB >> 12816996

Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.

Rish K Pai1, Marilyn Convery, Thomas A Hamilton, W Henry Boom, Clifford V Harding.   

Abstract

Mycobacterium tuberculosis (MTB) persists inside macrophages despite vigorous immune responses. MTB and MTB 19-kDa lipoprotein inhibit class II MHC (MHC-II) expression and Ag processing by a Toll-like receptor 2-dependent mechanism that is shown in this study to involve a defect in IFN-gamma induction of class II transactivator (CIITA). Exposure of macrophages to MTB or MTB 19-kDa lipoprotein inhibited IFN-gamma-induced MHC-II expression, but not IL-4-induced MHC-II expression, by preventing induction of mRNA for CIITA (total, type I, and type IV), IFN regulatory factor-1, and MHC-II. MTB 19-kDa lipoprotein induced mRNA for suppressor of cytokine signaling (SOCS)1 but did not inhibit IFN-gamma-induced Stat1 phosphorylation. Furthermore, the lipoprotein inhibited MHC-II Ag processing in SOCS1(-/-) macrophages. MTB 19-kDa lipoprotein did not inhibit translocation of phosphorylated Stat1 to the nucleus or Stat1 binding to and transactivation of IFN-gamma-sensitive promoter constructs. Thus, MTB 19-kDa lipoprotein inhibited IFN-gamma signaling independent of SOCS1 and without interfering with the activation of Stat1. Inhibition of IFN-gamma-induced CIITA by MTB 19-kDa lipoprotein may allow MTB to evade detection by CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816996     DOI: 10.4049/jimmunol.171.1.175

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  96 in total

1.  Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.

Authors:  Michela Sali; Gabriele Di Sante; Alessandro Cascioferro; Antonella Zumbo; Chiara Nicolò; Valentina Donà; Stefano Rocca; Annabella Procoli; Matteo Morandi; Francesco Ria; Giorgio Palù; Giovanni Fadda; Riccardo Manganelli; Giovanni Delogu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

Review 3.  Mycobacteria-induced suppression of autoimmunity in the central nervous system.

Authors:  JangEun Lee; Matyas Sandor; Erika Heninger; Zsuzsanna Fabry
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-24       Impact factor: 4.147

4.  The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes.

Authors:  Saet-Byel Jung; Chul-Su Yang; Ji-Sook Lee; A-Rum Shin; Sung-Soo Jung; Ji Woong Son; Clifford V Harding; Hwa-Jung Kim; Jeong-Kyu Park; Tae-Hyun Paik; Chang-Hwa Song; Eun-Kyeong Jo
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Authors:  Supriya Shukla; Edward T Richardson; Michael G Drage; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

7.  Transcriptional control of the mycobacterial embCAB operon by PknH through a regulatory protein, EmbR, in vivo.

Authors:  Kirti Sharma; Meetu Gupta; Monika Pathak; Nidhi Gupta; Anil Koul; Smilona Sarangi; Renu Baweja; Yogendra Singh
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

8.  CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein.

Authors:  Meghan E Pennini; Yi Liu; Jianqi Yang; Colleen M Croniger; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

Review 9.  Disruption of immune regulation by microbial pathogens and resulting chronic inflammation.

Authors:  Kenneth Barth; Daniel G Remick; Caroline A Genco
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

10.  Suppression of autophagy and antigen presentation by Mycobacterium tuberculosis PE_PGRS47.

Authors:  Neeraj K Saini; Andres Baena; Tony W Ng; Manjunatha M Venkataswamy; Steven C Kennedy; Shajo Kunnath-Velayudhan; Leandro J Carreño; Jiayong Xu; John Chan; Michelle H Larsen; William R Jacobs; Steven A Porcelli
Journal:  Nat Microbiol       Date:  2016-08-15       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.